{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer", "flavonoids", "miRNAs", "molecular targets", "molecular-simulation", "narirutin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35040205", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "18"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1002/ptr.7367"], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "36", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Feb"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "Dietary flavonoid narirutin as a prospective antagonist of oncogenic pri/pre-microRNAs.", "Pagination": {"StartPage": "963", "EndPage": "983", "MedlinePgn": "963-983"}, "Abstract": {"AbstractText": ["MicroRNAs (miRNAs) are involved in cancer progression via translational degradation in a sequence-specific manner of the 3'-untranslated region (3'UTR) of messenger RNA (mRNA). The involvement of miRNA in the biological progression of various cancer types is considered to be a potential target. Primary miRNA (pri-miRNA) and precursor-miRNA (pre-miRNA) synthesize the miRNA by dicer-catalyzed processes thus targeting pri/pre-miRNA by phytochemicals is amongst the appropriate approaches for anticancer therapies. Flavonoids category of phytochemicals is well-known for its chemotherapeutic and chemopreventive potential against multiple cancer types. However, the molecular interactions of flavonoids with miRNAs are not reported so far. Thus, this study aims to identify the promising flavonoids as the antagonist of miRNAs (pre-miR21, pri-miR-208a, pri-miR-378a, pri-miR320b, pri-miR-300, pri-miR-19b, and pre-miR-20b) using molecular docking simulations studies. Among the tested flavonoids, narirutin showed highest binding energy (-11.7\u00a0kcal/mol) against pri-miR19b followed by pri-miR-378a (-11.4\u00a0kcal/mol)\u2009> \u2009pri-miR320b (-11.2\u00a0kcal/mol)\u2009= \u2009pri-miR-300 (-11.2\u00a0kcal/mol)\u2009> \u2009pri-miR-208a (-9.0\u00a0kcal/mol)\u2009> \u2009pre-miR-20b (- 8.3\u00a0kcal/mol). The molecular dynamic simulation experiment confirmed that narirutin destabilizes the tertiary structure of pri-miRNA in comparison to apo-RNA. The finding indicates that narirutin binding with pre-miRNA causes disruption of pri-RNA structure that creates a loss of DICER-pre-miRNA interactions by hindering the pre-miRNA synthesis, thereby affecting miRNA processing. Further pharmacokinetics and toxicity prediction revealed that it is non-carcinogenic, non-mutagenic, and does not inhibit the CYPs activity. Thus, narirutin could be a possible antagonist of oncogenic miRNAs, therefore could be useful for miRNA-targeted cancer prevention and treatment."], "CopyrightInformation": "\u00a9 2022 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India."}], "LastName": "Singh", "ForeName": "Shilpi", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Microbiology and Immunology Division, CSIR-Central Drug Research Institute, Jankipuram Extension, Lucknow, India."}], "LastName": "Srivastava", "ForeName": "Pratik Narain", "Initials": "PN"}, {"Identifier": ["0000-0002-1014-1486"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India."}], "LastName": "Meena", "ForeName": "Abha", "Initials": "A"}, {"Identifier": ["0000-0001-6568-8107"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India."}], "LastName": "Luqman", "ForeName": "Suaib", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Disaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavanones"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "06M5EAT0YC", "NameOfSubstance": "narirutin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Disaccharides"}, {"QualifierName": [], "DescriptorName": "Flavanones"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "MicroRNAs"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Prospective Studies"}, {"QualifierName": [], "DescriptorName": "RNA Processing, Post-Transcriptional"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Babashah, S., Bakhshinejad, B., Birgani, M. T., Pakravan, K., & Cho, W. C. (2018). Regulation of microRNAs by phytochemicals: A promising strategy for cancer chemoprevention. Current Cancer Drug Targets, 18, 640-651. https://doi.org/10.2174/1568009617666170623124710"}, {"Citation": "Banerjee, P., Eckert, A. O., Schrey, A. K., & Preissner, R. (2018). ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46, W257-W263."}, {"Citation": "Baselga-Escudero, L., Blade, C., Ribas-Latre, A., Casanova, E., Suarez, M., Torres, J. L., \u2026 Arola-Arnal, A. (2013). Resveratrol and EGCG bind directly and distinctively to miR-33a and miR-122 and modulate divergently their levels in hepatic cells. Nucleic Acids Research, 42, 882-892."}, {"Citation": "Bautista-S\u00e1nchez, D., Arriaga-Canon, C., Pedroza-Torres, A., De La Rosa-Vel\u00e1zquez, I. A., Gonz\u00e1lez-Barrios, R., Contreras-Espinosa, L., \u2026 \u00c1lvarez-G\u00f3mez, R. M. (2020). The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics. Molecular Therapy--Nucleic Acids, 20, 409-420."}, {"Citation": "Cascio, S., D'Andrea, A., Ferla, R., Surmacz, E., Gulotta, E., Amodeo, V., \u2026 Russo, A. (2010). miR-20b modulates VEGF expression by targeting HIF-1\u03b1 and STAT3 in MCF-7 breast cancer cells. Journal of Cellular Physiology, 224, 242-249."}, {"Citation": "Chen, C. Z. (2013). An unsolved mystery: The target-recognizing RNA species of microRNA genes. Biochimie, 95(9), 1663-1676."}, {"Citation": "Chen, L., Xu, S., Xu, H., Zhang, J., Ning, J., & Wang, S. (2012). MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis. Medical Oncology, 29, 1673-1680."}, {"Citation": "Condrat, C. E., Thompson, D. C., Barbu, M. G., Bugnar, O. L., Boboc, A., Cretoiu, D., \u2026 Voinea, S. C. (2020). miRNAs as biomarkers in disease: Latest findings regarding their role in diagnosis and prognosis. Cell, 9(2), 276."}, {"Citation": "Cui, H.-B., Ge, H.-E., Wang, Y.-S., & Bai, X.-Y. (2018). MiR-208a enhances cell proliferation and invasion of gastric cancer by targeting SFRP1 and negatively regulating MEG3. The International Journal of Biochemistry & Cell Biology, 102, 31-39."}, {"Citation": "Davies, B. P., & Arenz, C. (2008). A fluorescence probe for assaying micro RNA maturation. Bioorganic & Medicinal Chemistry, 16, 49-55."}, {"Citation": "Davis, S., Lollo, B., Freier, S., & Esau, C. (2006). Improved targeting of miRNA with antisense oligonucleotides.. Nucleic acids research, 34(8), 2294-2304."}, {"Citation": "de Azevedo, W. F. (2011). Molecular dynamics simulations of protein targets identified in mycobacterium tuberculosis. Current Medicinal Chemistry, 18, 1353-1366."}, {"Citation": "Ding, L., Gu, H., Xiong, X., Ao, H., Cao, J., Lin, W., \u2026 Cui, Q. (2019). MicroRNAs involved in carcinogenesis, prognosis, therapeutic resistance, and applications in human triple-negative breast cancer. Cell, 8, 1492."}, {"Citation": "Eichner, L. J., Perry, M.-C., Dufour, C. R., Bertos, N., Park, M., St-Pierre, J., & Gigu\u00e8re, V. (2010). miR-378* mediates metabolic shift in breast cancer cells via the PGC-1\u03b2/ERR\u03b3 transcriptional pathway. Cell Metabolism, 12, 352-361."}, {"Citation": "Fan, R., Xiao, C., Wan, X., Cha, W., Miao, Y., Zhou, Y., \u2026 Shan, X. (2019). Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics. RNA Biology, 16(6), 707-718."}, {"Citation": "Fu, Y., Wang, Y., Bi, K., Yang, L., Sun, Y., Li, B., \u2026 Feng, C. (2020). MicroRNA-208a-3p promotes osteosarcoma progression via targeting PTEN. Experimental and Therapeutic Medicine, 20, 1-1."}, {"Citation": "Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., & Krichevsky, A. M. (2008). MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Molecular and Cellular Biology, 28, 5369-5380."}, {"Citation": "Gagliardi, M., & Ashizawa, A. T. (2021). The challenges and strategies of antisense oligonucleotide drug delivery. Biomedicine, 9(4), 433."}, {"Citation": "Guo, J., Xiao, Z., Yu, X., & Cao, R. (2017). miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer. Oncology Letters, 14, 6895-6900."}, {"Citation": "Gu, Y, Liu, S, Zhang, X, Chen, G, Liang, H, Yu, M, & Chen, X (2017). Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer. Protein & cell, 8(6), 455-466."}, {"Citation": "He, J., Mu, M., Luo, Y., Wang, H., Ma, H., Guo, S., \u2026 Song, C. (2019). MicroRNA-20b promotes proliferation of H22 hepatocellular carcinoma cells by targeting PTEN. Oncology Letters, 17, 2931-2936."}, {"Citation": "Heberl\u00e9, G., & de Azevedo, F. W. (2011). Bio-inspired algorithms applied to molecular docking simulations. Current Medicinal Chemistry, 18, 1339-1352."}, {"Citation": "Huang, J., & Mackerell, A. D. (2013). CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. Journal of Computational Chemistry, 34(25), 2135-2145."}, {"Citation": "Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14, 33-38."}, {"Citation": "Hussain, Y., Luqman, S., & Meena, A. (2020). Research progress in flavonoids as potential anticancer drug including synergy with other approaches. Current Topics in Medicinal Chemistry, 20, 1791-1809."}, {"Citation": "Jaudan, A., Sharma, S., Malek, S. N. A., & Dixit, A. (2018). Induction of apoptosis by pinostrobin in human cervical cancer cells: Possible mechanism of action. PLoS One, 13, e0191523."}, {"Citation": "Junaid, M., Dash, R., Islam, N., Chowdhury, J., Alam, M. J., Nath, S. D., \u2026 Hosen, S. Z. (2017). Molecular simulation studies of 3, 3\u2032-Diindolylmethane as a potent MicroRNA-21 antagonist. Journal of Pharmacy & Bioallied Sciences, 9, 259."}, {"Citation": "Katada, T., Ishiguro, H., Kuwabara, Y., Kimura, M., Mitui, A., Mori, Y., \u2026 Fujii, Y. (2009). microRNA expression profile in undifferentiated gastric cancer. International Journal of Oncology, 34, 537-542."}, {"Citation": "Kooistra, S. M., N\u00f8rgaard, L. C. R., Lees, M. J., Steinhauer, C., Johansen, J. V., & Helin, K. (2014). A screen identifies the oncogenic micro-RNA miR-378a-5p as a negative regulator of oncogene-induced senescence. PLoS One, 9, e91034."}, {"Citation": "Lee, D. Y., Deng, Z., Wang, C.-H., & Yang, B. B. (2007). MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proceedings of the National Academy of Sciences, 104, 20350-20355."}, {"Citation": "Lei, Z., Li, B. O., Yang, Z., Fang, H., Zhang, G.-M., Feng, Z.-H., & Huang, B. (2009). Regulation of HIF-1\u03b1 and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS One, 4, e7629."}, {"Citation": "Li, C., Zhang, J., Ma, Z., Zhang, F., & Yu, W. (2018). miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway. OncoTargets and Therapy, 11, 4087-4095."}, {"Citation": "Li, H., Zheng, D., Zhang, B., Liu, L., Ou, J., Chen, W., \u2026 Yang, J. (2014). Mir-208 promotes cell proliferation by repressing SOX6 expression in human esophageal squamous cell carcinoma. Journal of Translational Medicine, 12, 1-9."}, {"Citation": "Lieb, V., Weigelt, K., Scheinost, L., Fischer, K., Greither, T., Marcou, M., \u2026 Lai, X. (2018). Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patients. Oncotarget, 9, 10402-10416."}, {"Citation": "Liu, L., Wang, W., Gao, S., & Wang, X. (2019). MicroRNA-208a directly targets Src kinase signaling inhibitor 1 to facilitate cell proliferation and invasion in non-small cell lung cancer. Molecular Medicine Reports, 20, 3140-3148."}, {"Citation": "Lu, K., Liu, C., Tao, T., Zhang, X., Zhang, L., Sun, C., \u2026 Chen, M. (2015). MicroRNA-19a regulates proliferation and apoptosis of castration-resistant prostate cancer cells by targeting BTG1. FEBS Letters, 589, 1485-1490."}, {"Citation": "Lundin, K. E., Gissberg, O., & Smith, C. E. (2015). Oligonucleotide therapies: The past and the present. Human Gene Therapy, 26(8), 475-485."}, {"Citation": "Luo, Q.-J., Zhang, J., Li, P., Wang, Q., Zhang, Y., Roy-Chaudhuri, B., \u2026 Zhang, Q. C. (2021). RNA structure probing reveals the structural basis of dicer binding and cleavage. Nature Communications, 12(1), 3397."}, {"Citation": "Medina, P. P., Nolde, M., & Slack, F. J. (2010). OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature, 467, 86-90."}, {"Citation": "Monroig, P. D. C., Chen, L., Zhang, S., & Calin, G. A. (2015). Small molecule compounds targeting miRNAs for cancer therapy. Advanced Drug Delivery Reviews, 81, 104-116."}, {"Citation": "Niu, F., Dzikiewicz-Krawczyk, A., Koerts, J., de Jong, D., Wijenberg, L., Fernandez Hernandez, M., \u2026 van der Sluis, T. (2020). MiR-378a-3p is critical for Burkitt lymphoma cell growth. Cancers, 12, 3546."}, {"Citation": "Peng, Y., & Croce, C. M. (2016). The role of microRNAs in human cancer. Signal Transduction and Targeted Therapy, 1, 1-9."}, {"Citation": "Phillips, J. C., Hardy, D. J., Maia, J. D. C., Stone, J. E., Ribeiro, J. V., Bernardi, R. C., \u2026 Tajkhorshid, E. (2020). Scalable molecular dynamics on CPU and GPU architectures with NAMD. The Journal of Chemical Physics, 153(4), 044130."}, {"Citation": "Qian, B., Katsaros, D., Lu, L., Preti, M., Durando, A., Arisio, R., \u2026 Yu, H. (2009). High miR-21 expression in breast cancer associated with poor disease-free survival in early-stage disease and high TGF-\u03b21. Breast Cancer Research and Treatment, 117, 131-140."}, {"Citation": "Rademann, K. (1990). P. W. Atkins: Physical chemistry, 4th edition, Oxford university press, Oxford, ISBN 0-19-855284-X, 1990. 995 seiten, Preis: \u00a3 19.50 (paperback). Berichte der Bunsengesellschaft f\u00fcr Physikalische Chemie, 94, 1171-1171. https://doi.org/10.1002/bbpc.19900941026"}, {"Citation": "Sayeed, M. A., Bracci, M., Lazzarini, R., Tomasetti, M., Amati, M., Lucarini, G., \u2026 Santarelli, L. (2017). Use of potential dietary phytochemicals to target miRNA: Promising option for breast cancer prevention and treatment? Journal of Functional Foods, 28, 177-193. https://doi.org/10.1016/j.jff.2016.11.008"}, {"Citation": "Sayeed, M. A., Bracci, M., Lucarini, G., Lazzarini, R., Di Primio, R., & Santarelli, L. (2017). Regulation of microRNA using promising dietary phytochemicals: Possible preventive and treatment option of malignant mesothelioma. Biomedicine & Pharmacotherapy, 94, 1197-1224. https://doi.org/10.1016/j.biopha.2017.07.075"}, {"Citation": "Schyman, P., Liu, R., Desai, V., & Wallqvist, A. (2017). vNN web server for ADMET predictions. Frontiers in Pharmacology, 8, 889."}, {"Citation": "Shah, V., & Shah, J. (2020). Recent trends in targeting miRNAs for cancer therapy. The Journal of Pharmacy and Pharmacology, 72, 1732-1749."}, {"Citation": "Shi, Z., Zhang, J., Qian, X., Han, L., Zhang, K., Chen, L., \u2026 Pu, P. (2013). AC1MMYR2, an inhibitor of dicer-mediated biogenesis of oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression. Cancer Research, 73(17), 5519-5531."}, {"Citation": "Si, M. L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y. Y. (2007). miR-21-mediated tumor growth. Oncogene, 26, 2799-2803."}, {"Citation": "Singh, S., Gupta, P., Meena, A., & Luqman, S. (2020). Acacetin, a flavone with diverse therapeutic potential in cancer, inflammation, infections and other metabolic disorders. Food and Chemical Toxicology, 145, 111708."}, {"Citation": "Singh, S., Kumari, P., Hussain, Y., Luqman, S., Meena, A., & Kanaojia, D. (2020). Isothymusin, a potential inhibitor of cancer cell proliferation: An in silico and in vitro investigation. Current Topics in Medicinal Chemistry, 20, 1898-1909."}, {"Citation": "Singh, S., Meena, A., & Luqman, S. (2020). Baicalin mediated regulation of key signaling pathways in cancer. Pharmacological Research, 164, 105387."}, {"Citation": "Singh, S., Meena, A., Luqman, S., & Meena, A. (2021). Acacetin and pinostrobin as a promising inhibitor of cancer-associated protein kinases. Food and Chemical Toxicology, 151, 112091."}, {"Citation": "Singh, S., Raza, W., Parveen, S., Meena, A., & Luqman, S. (2021). Flavonoids display ability to target microRNAs in cancer pathogenesis. Biochemical Pharmacology, 189, 114409."}, {"Citation": "Song, M., Sun, M., Xia, L., Chen, W., & Yang, C. (2019). miR-19b-3p promotes human pancreatic cancer Capan-2 cells proliferation by targeting phosphatase and tension homolog. Annals of Translational Medicine, 7, 236-242."}, {"Citation": "Sun, X., Jiang, S., Liu, J., Wang, H., Zhang, Y., Tang, S.-C., \u2026 Wang, C. (2015). MiR-208a stimulates the cocktail of SOX2 and \u03b2-catenin to inhibit the let-7 induction of self-renewal repression of breast cancer stem cells and formed miR208a/let-7 feedback loop via LIN28 and DICER1. Oncotarget, 6, 32944-32954."}, {"Citation": "Tadano, T., Kakuta, Y., Hamada, S., Shimodaira, Y., Kuroha, M., Kawakami, Y., \u2026 Masamune, A. (2016). MicroRNA-320 family is downregulated in colorectal adenoma and affects tumor proliferation by targeting CDK6. World Journal of Gastrointestinal Oncology, 8, 532-542."}, {"Citation": "Tang, Y., Cui, Y., Li, Z., Jiao, Z., Zhang, Y., He, Y., \u2026 Zhou, X. (2016). Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells. Journal of Experimental & Clinical Cancer Research, 35, 1-14."}, {"Citation": "Thomas, J. R., & Hergenrother, P. J. (2008). Targeting RNA with small molecules. Chemical Reviews, 108, 1171-1224."}, {"Citation": "Trott, O., & Olson, A. J. (2010). AutoDock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455-461."}, {"Citation": "Tupone, M. G., D'Aguanno, S., Di Martile, M., Valentini, E., Desideri, M., Trisciuoglio, D., \u2026 Ercolani, C. (2020). microRNA-378a-5p iS a novel positive regulator of melanoma progression. Oncogene, 9, 1-13."}, {"Citation": "Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., \u2026 Mackerell, A. D. (2010). CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. Journal of Computational Chemistry, 31(4), 671-690."}, {"Citation": "Wang, H., Cao, F., Li, X., Miao, H., Jifu, E., Xing, J., & Fu, C. (2015). miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cells. BMC Cancer, 15, 1-9."}, {"Citation": "Wang, H., Peng, R., Wang, J., Qin, Z., & Xue, L. (2018). Circulating microRNAs as potential cancer biomarkers: The advantage and disadvantage. Clinical Epigenetics, 10(1), 1-10."}, {"Citation": "Wang, J., Zhao, H., Yu, J., Xu, X., Jing, H., Li, N., \u2026 Cai, J. (2021). MiR-320b/RAD21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling. Cancer Science, 112, 575-588."}, {"Citation": "Wang, K.-J., Zhao, X., Liu, Y.-Z., Zeng, Q.-T., Mao, X.-B., Li, S.-N., \u2026 Qian, C. (2016). Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are promising novel biomarkers for early diagnosis of acute myocardial infarction. Cellular Physiology and Biochemistry, 38, 1015-1029."}, {"Citation": "Wang, L., & Yu, P. (2016). miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53. Oncology Reports, 36, 3225-3232."}, {"Citation": "Wang, L., Wang, X., Chen, H., Zu, X., Ma, F., Liu, K., \u2026 Kim, D. J. (2019). Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2. Phytotherapy Research, 33, 640-650."}, {"Citation": "Wang, L., Yang, G., Zhao, D., Wang, J., Bai, Y., Peng, Q., \u2026 Wang, Z. (2019). CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: Role of remote MiR-19b-3p. Molecular Cancer, 18, 1-15."}, {"Citation": "Wen, D., Danquah, M., Chaudhary, A. K., & Mahato, R. I. (2015). Small molecules targeting microRNA for cancer therapy: Promises and obstacles. Journal of Controlled Release, 219, 237-247."}, {"Citation": "Wu, H., Xu, L., Chen, Y., & Xu, C. (2019). MiR-208a-3p functions as an oncogene in colorectal cancer by targeting PDCD4. Bioscience Reports, 39, 39."}, {"Citation": "Xu, X.-H., Li, D.-W., Feng, H., Chen, H.-M., & Song, Y.-Q. (2015). MiR-300 regulate the malignancy of breast cancer by targeting p53. International Journal of Clinical and Experimental Medicine, 8, 6957-6966."}, {"Citation": "Xue, T., Li-de Tao, M. Z., Xu, G., Zhang, J., & Zhang, P.-J. (2015). miR-20b overexpression is predictive of poor prognosis in gastric cancer. OncoTargets and Therapy, 8, 1871."}, {"Citation": "Xue, Z., Zhao, J., Niu, L., An, G., Guo, Y., & Ni, L. (2015). Up-regulation of MiR-300 promotes proliferation and invasion of osteosarcoma by targeting BRD7. PLoS One, 10, e0127682."}, {"Citation": "Yamada, S., Tsukamoto, S., Huang, Y., Makio, A., Kumazoe, M., Yamashita, S., & Tachibana, H. (2016). Epigallocatechin-3-O-gallate up-regulates microRNA-let-7b expression by activating 67-kDa laminin receptor signaling in melanoma cells. Scientific Reports, 6, 1-8."}, {"Citation": "Yang, L., Zhang, W., Chopra, S., Kaur, D., Wang, H., Li, M., \u2026 Zhang, W. (2020). The epigenetic modification of epigallocatechin Gallate (EGCG) on cancer. Current Drug Targets, 21, 1099-1104."}, {"Citation": "Yin, K., Liu, M., Zhang, M., Wang, F., Fen, M., Liu, Z., \u2026 Zhang, W. (2016). miR-208a-3p suppresses cell apoptosis by targeting PDCD4 in gastric cancer. Oncotarget, 7, 67321-67332."}, {"Citation": "Zhang, D., Yang, G., Chen, X., Li, C., Wang, L., Liu, Y., \u2026 Zhang, W. (2014). Mir-300 promotes self-renewal and inhibits the differentiation of glioma stem-like cells. Journal of Molecular Neuroscience, 53, 637-644."}, {"Citation": "Zhang, J., Luo, H., Du, J., & Liu, Y. (2016). MicroRNA-300 plays as oncogene by promoting proliferation and reducing apoptosis of liver cancer cells by targeting MDC1. International Journal of Clinical and Experimental Pathology, 9, 1231-1239."}, {"Citation": "Zhang, L., Ai, H., Chen, W., Yin, Z., Hu, H., Zhu, J., \u2026 Liu, H. (2017). CarcinoPred-EL: Novel models for predicting the carcinogenicity of chemicals using molecular fingerprints and ensemble learning methods. Scientific Reports, 7, 1-14."}, {"Citation": "Zhou, D.-H., Wang, X., & Feng, Q. (2014). EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 cells. Nutrition and Cancer, 66, 636-644."}, {"Citation": "Zhou, J., Zhang, M., Huang, Y., Feng, L., Chen, H., Hu, Y., \u2026 Zheng, S. (2015). MicroRNA-320b promotes colorectal cancer proliferation and invasion by competing with its homologous microRNA-320a. Cancer Letters, 356, 669-675."}, {"Citation": "Zhou, W., Shi, G., Zhang, Q., Wu, Q., Li, B., & Zhang, Z. (2014). MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN). Cell & Bioscience, 4, 1-11."}, {"Citation": "Zhu, J., Chen, L., Zou, L., Yang, P., Wu, R., Mao, Y., \u2026 Wang, W. (2014). MiR-20b,-21, and-130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer. Human Immunology, 75, 348-353."}, {"Citation": "Zhu, K., & Wang, W. (2016). Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1. Tumor Biology, 37, 4373-4382."}, {"Citation": "Zou, Y., Zheng, S., Xiao, W., Xie, X., Yang, A., Gao, G., \u2026 Xie, X. (2019). circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression. Carcinogenesis, 40, 1469-1479."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2021", "Month": "12", "Day": "2"}, {"Year": "2021", "Month": "7", "Day": "17"}, {"Year": "2021", "Month": "12", "Day": "11"}, {"Year": "2022", "Month": "1", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "18", "Hour": "6", "Minute": "18"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35040205", "10.1002/ptr.7367"]}}], "PubmedBookArticle": []}